Institute of Health and Sport; Victoria University, Melbourne, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), Victoria University, St. Albans, Victoria, Australia.
J Appl Physiol (1985). 2019 Aug 1;127(2):581-590. doi: 10.1152/japplphysiol.01011.2018. Epub 2019 Jan 24.
Skeletal muscle mass is, in part, regulated by the rate of mRNA translation (i.e., protein synthesis). The conserved serine/threonine kinase, mTOR (the mammalian/mechanistic target of rapamycin), found in the multiprotein complex, mTOR complex 1 (mTORC1), is a major positive regulator of protein synthesis. The purpose of this review is to describe some of the critical steps in translation initiation, mTORC1 and its potential direct and indirect roles in regulating translation, and evidence that mTORC1 regulates protein synthesis and muscle mass, with a particular focus on basal conditions and the response to mechanical stimuli. Current evidence suggests that for acute contraction models of mechanical stimuli, there is an emerging pattern suggesting that there is an early increase in protein synthesis governed by a rapamycin-sensitive mTORC1-dependent mechanism, while at later poststimulation time points, the mechanism may change to a rapamycin-insensitive mTORC1-dependent or even an mTORC1-independent mechanism. Furthermore, evidence suggests that mTORC1 appears to be absolutely necessary for muscle fiber hypertrophy induced by chronic mechanical loading but may only play a partial role in the hypertrophy induced by more intermittent types of acute resistance exercise, with the possibility of mTORC1-independent mechanisms also playing a role. Despite the progress that has been made, many questions about the activation of mTORC1, and its downstream targets, remain to be answered. Further research will hopefully provide novel insights into the regulation of skeletal muscle mTORC1 that may eventually be translated into novel exercise programing and/or targeted pharmacological therapies aimed at preventing muscle wasting and/or increasing muscle mass.
骨骼肌质量部分受 mRNA 翻译(即蛋白质合成)的速率调节。在多蛋白复合物 mTOR 复合物 1(mTORC1)中发现的保守丝氨酸/苏氨酸激酶 mTOR(哺乳动物/雷帕霉素的机制靶点)是蛋白质合成的主要正调节剂。本综述的目的是描述翻译起始、mTORC1 及其在调节翻译中的潜在直接和间接作用的一些关键步骤,以及 mTORC1 调节蛋白质合成和肌肉质量的证据,特别关注基础条件和对机械刺激的反应。目前的证据表明,对于机械刺激的急性收缩模型,有一个新出现的模式表明,存在一个由雷帕霉素敏感的 mTORC1 依赖性机制控制的早期蛋白质合成增加,而在稍后的刺激后时间点,该机制可能变为雷帕霉素不敏感的 mTORC1 依赖性甚至 mTORC1 非依赖性机制。此外,有证据表明,mTORC1 似乎是慢性机械负荷引起的肌纤维肥大所必需的,但在更间歇性的急性抗阻运动引起的肥大中可能只起部分作用,mTORC1 非依赖性机制也可能起作用。尽管已经取得了进展,但关于 mTORC1 的激活及其下游靶标仍有许多问题需要回答。进一步的研究有望为调节骨骼肌 mTORC1 提供新的见解,最终可能转化为新的运动编程和/或靶向药理学治疗,以防止肌肉减少和/或增加肌肉质量。